Summary
FDA-approved prescribing information
Study Details
Study Design
FDA-approved labeling
Indication
HSDD
Intervention
Bremelanotide 1.75 mg SC
Species
Human
Tags
SourceFDARegulatoryBremelanotideVyleesiLabel
Metrics
Citations
0Evidence QualityN/A
Related PeptideBremelanotide8 papers